After bidding war, North Bay drug maker snags gene therapy company for $151 million
October 03, 2017 at 13:20 PM EDT
The offer from Ultragenyx Pharmaceutical beat out an earlier proposal by a Maryland biotech.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.